Scientists from Moscow State University (MSU) working with an international team of researchers have identified the structure of one of the key regions of telomerase—a so-called “cellular immortality” ribonucleoprotein. Structural and functional studies on this protein are important for the development of potential anticancer drugs. The results of the study have been published in Nucleic Acids Research.